GLP-1 users are posting about side effects and symptoms not seen in clinical trials, including irregular periods, fatigue, ...
Researchers analysed more than 400,000 social media posts in a bid to identify lesser-known issues linked to widely used GLP-1 medications semaglutide and tirzepatide.